Status:
COMPLETED
Enhanced Care Coordination for Head and Neck Cancer Survivors
Lead Sponsor:
University of Pittsburgh
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of a multidimensional symptom management intervention on decreasing symptom burden and thus reducing hospital utilization in patients undergoing rad...
Detailed Description
The purpose of this study is to evaluate the effect of a multidimensional symptom assessment intervention on identifying symptoms and alerting care team of changes, and thus reducing hospital utilizat...
Eligibility Criteria
Inclusion
- Age 18 and older
- Diagnosed with primary, head and neck cancer of the paranasal sinuses, nasal cavity, oral cavity, tongue, salivary glands, larynx, and pharynx (including the nasopharynx, oropharynx, and hypopharynx)
- Will include squamous cell carcinoma found in lymph nodes as a result of unknown primary location.
- Prior to the initiation of radiation treatment for qualifying diagnosis
- Treatment occurring at Hillman Cancer Center
Exclusion
- Prior radiation treatment of squamous cell carcinoma of the locations listed in inclusion criteria.
Key Trial Info
Start Date :
January 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04813172
Start Date
January 8 2020
End Date
July 31 2024
Last Update
January 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye and Ear Institute
Pittsburgh, Pennsylvania, United States, 15213